- 专利标题： ANTIVIRAL COMPOUNDS
-
申请号： US17208964申请日： 2021-03-22
-
公开(公告)号： US20220363640A1公开(公告)日： 2022-11-17
- 发明人: Guangyi WANG , Leonid BEIGELMAN , Anh TRUONG , Carmela NAPOLITANO , Daniele ANDREOTTI , Haiying HE , Karin Ann STEIN
- 申请人： Janssen BioPharma, Inc.
- 申请人地址： US CA South San Francisco
- 专利权人： Janssen BioPharma, Inc.
- 当前专利权人： Janssen BioPharma, Inc.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： C07D213/40
- IPC分类号： C07D213/40 ; C07D409/04 ; C07D495/14 ; C07D401/04 ; C07D413/04 ; C07D417/04 ; C07D239/34 ; C07D471/04 ; C07D213/65 ; C07D401/12 ; C07D491/048 ; C07D233/64 ; C07D409/14 ; C07D417/06 ; C07D413/12 ; C07D413/06 ; C07D401/06 ; C07D405/12 ; C07D417/12 ; C07D207/273 ; C07D491/052 ; A61K31/4436 ; A61K31/4418 ; A61K31/4178 ; A61K31/4439 ; A61K31/4365 ; A61K31/422 ; A61K31/4196 ; A61K31/427 ; A61K31/505 ; A61K31/437 ; A61K45/06 ; A61K31/4355 ; A61K31/444 ; A61K31/4709
摘要：
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).